glutathione and triple negative breast cancer Ratiometrically designed nanoprodrug for triple-negative treatment NRF2 activation by cysteine as
NRF2 activation by cysteine as a survival mechanism for triple negative breast cancer cells Oncogene glutathione autophagy Regulatory network of ferroptosis and by targeting oxidative stress defense using sulfasalazine in triple negative breast cancer Apoptosis and glutathione: beyond an Targeting the redox programmed cell death axis in breast cancer: from molecular mechanisms to therapeutic resistance Cell Death Discovery Full article: Glutathione and acid dual responsive nanomaterials loaded with methotrexate and magnolol for triple negative breast cancer treatment Excessive glutathione intake contributes to chemotherapy resistance in breast cancer: a propensity score matching analysis PMC
Pay in 4 interest-free payments of $7.00 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 16 - Sep 21




